rs144413438

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_000395.3(CSF2RB):​c.2431G>A​(p.Glu811Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000115 in 1,614,016 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00011 ( 1 hom. )

Consequence

CSF2RB
NM_000395.3 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 1.08
Variant links:
Genes affected
CSF2RB (HGNC:2436): (colony stimulating factor 2 receptor subunit beta) The protein encoded by this gene is the common beta chain of the high affinity receptor for IL-3, IL-5 and CSF. Defects in this gene have been reported to be associated with protein alveolar proteinosis (PAP). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.12783387).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CSF2RBNM_000395.3 linkuse as main transcriptc.2431G>A p.Glu811Lys missense_variant 14/14 ENST00000403662.8 NP_000386.1 P32927-1Q6NSJ8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CSF2RBENST00000403662.8 linkuse as main transcriptc.2431G>A p.Glu811Lys missense_variant 14/145 NM_000395.3 ENSP00000384053.3 P32927-1
CSF2RBENST00000406230.5 linkuse as main transcriptc.2449G>A p.Glu817Lys missense_variant 13/131 ENSP00000385271.1 P32927-2

Frequencies

GnomAD3 genomes
AF:
0.000125
AC:
19
AN:
152170
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000279
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000994
AC:
25
AN:
251392
Hom.:
0
AF XY:
0.000118
AC XY:
16
AN XY:
135870
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000193
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000114
AC:
167
AN:
1461846
Hom.:
1
Cov.:
35
AF XY:
0.000105
AC XY:
76
AN XY:
727220
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000447
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000145
Gnomad4 OTH exome
AF:
0.0000497
GnomAD4 genome
AF:
0.000125
AC:
19
AN:
152170
Hom.:
0
Cov.:
32
AF XY:
0.000148
AC XY:
11
AN XY:
74346
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000279
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000225
Hom.:
0
Bravo
AF:
0.0000907
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000659
AC:
8
EpiCase
AF:
0.000218
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineApr 10, 2017Variant classified as Uncertain Significance - Favor Benign. The p.Glu811Lys var iant in CSF2RB has not been previously reported in individuals with pulmonary di sease, but has been identified in 8/66686 European chromosomes by the Exome Aggr egation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs144413438). Gl utamic acid (Glu) at position 811 is not conserved in mammals or evolutionarily distant species and 2 mammals (rabbit and elephant) carry a lysine (Lys) at this position, raising the possibility that this change may be tolerated. In summary , while the clinical significance of the p.Glu811Lys variant is uncertain, these data suggest that it is more likely to be benign. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 27, 2024The c.2431G>A (p.E811K) alteration is located in exon 14 (coding exon 13) of the CSF2RB gene. This alteration results from a G to A substitution at nucleotide position 2431, causing the glutamic acid (E) at amino acid position 811 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 26, 2024This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 811 of the CSF2RB protein (p.Glu811Lys). This variant is present in population databases (rs144413438, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with CSF2RB-related conditions. ClinVar contains an entry for this variant (Variation ID: 504875). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CSF2RB protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.34
T;T;.
Eigen
Benign
-0.15
Eigen_PC
Benign
-0.13
FATHMM_MKL
Benign
0.47
N
LIST_S2
Benign
0.79
T;T;T
M_CAP
Benign
0.052
D
MetaRNN
Benign
0.13
T;T;T
MetaSVM
Uncertain
-0.19
T
MutationAssessor
Benign
1.2
L;.;.
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-1.5
N;.;N
REVEL
Benign
0.28
Sift
Benign
0.10
T;.;T
Sift4G
Benign
0.45
T;T;T
Polyphen
0.60
P;.;P
Vest4
0.12
MVP
0.90
MPC
0.26
ClinPred
0.048
T
GERP RS
3.4
Varity_R
0.073
gMVP
0.24

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs144413438; hg19: chr22-37334281; COSMIC: COSV53261154; API